Australian Clinical Trials

Clinical Trials Related to EB in Australia

The following clinical trials in EB are currently active in Australia. Anyone who is interested is encouraged to contact one of the study centres to obtain more information about the trial.

Trial Status Links for More Information
An International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study With Open-Label Extension Evaluating the Efficacy and Safety of Diacerein 1% Ointment for the Treatment of Generalized Epidermolysis Bullosa Simplex (EBS) Recruiting  

ANZCTR – Registration
For full trial details, please see the original record at https://clinicaltrials.gov/ct2/show/NCT06073132

More information here.

 

Phase III Efficacy and Safety Study of Oleogel-S10 in Epidermolysis Bullosa (EASE) Recruiting https://clinicaltrials.gov

Study identifier NCT03068780

BEB-13 Trial Information Sheet

Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study Study Closed https://clinicaltrials.gov

Study identifier NCT03016715

Sirolimus Trial Introductory Letter

An International, Multicenter, Randomized, Double-Blind, Parallel-Group Phase 2 Study Evaluating the Safety and Efficacy of Diacerein 1% Ointment Topical Formulation in Subjects with Epidermolysis Bullosa Simplex (EBS) Study Closed https://clinicaltrials.gov

Study identifier: NCT03154333

Study Language for Patient Advocacy Website: http://www.deliversebs.com

Read Document